BioAge Labs, Inc. BIOA
- BGE-102 — Atherosclerotic Cardiovascular Disease Phase 2
- BGE-102 — Diabetic Macular Edema Phase 1
NLRP3 (2 companies · 3 programs)
Companies with an active program directed at NLRP3.
AC Immune SA ACIU
- ACI-19764 Phase 1
Companies with an active program directed at NLRP3.